Uses
For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.
Source: US FDA prescribing information
Fixed-dose combination
Bacitracin zinc and Polymyxin b
Also known as bacitracin zinc, polymyxin b sulfate
Available on request
- Presentations
- 2
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Bacitracin zinc and Polymyxin b is a fixed-dose combination medicine. It is available as eye ointment for ophthalmic use. MedsAcross supplies Bacitracin zinc and Polymyxin b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Polymyxin-class Antibacterial, Decreased Cell Wall Synthesis & Repair
- US FDA first approval
- Approved
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Ophthalmic
- Dosage forms
- Eye ointment
- Fixed-dose combination of
- Bacitracin zinc, Polymyxin b
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection. FOR OPHTHALMIC USE ONLY
Source: US FDA prescribing information
Contraindications
This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Source: US FDA prescribing information
Warnings and precautions
Ophthalmic ointments may retard corneal healing.
Source: US FDA prescribing information
Storage
Store between 15°C to 25°C (59°F to 77°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
2 presentations of Bacitracin zinc and Polymyxin b, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Bacitracin zinc and Polymyxin b 500 units/10000 units per g eye ointmentOphthalmicGeneric name | Bacitracin zinc and Polymyxin b | — | US FDA | Available on request |
| polycin 500 units/10000 units per g eye ointmentOphthalmic | Bacitracin zinc and Polymyxin b | NuCare Pharmaceuticals,Inc | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Bacitracin zinc and Polymyxin b available for export from India?
Yes, on request. MedsAcross lists 2 presentations of Bacitracin zinc and Polymyxin b and sources them for licensed hospitals, importers and physicians against valid import documents.
What brand names does Bacitracin zinc and Polymyxin b have?
The catalogue lists 1 brand names for Bacitracin zinc and Polymyxin b, including polycin.
Does Bacitracin zinc and Polymyxin b need cold chain shipping?
No listed presentation of Bacitracin zinc and Polymyxin b is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Bacitracin Zinc and Polymyxin B Sulfate prescribing information (Bausch & Lomb). U.S. National Library of Medicine, DailyMed. Retrieved 18 October 2024
Request Bacitracin zinc and Polymyxin b for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.